 Setareh Salehi Omran
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 23 | 2025 | 1070 | 3.870 |
Why?
| | Carotid Artery, Internal, Dissection | 7 | 2025 | 13 | 1.720 |
Why?
| | Vertebral Artery Dissection | 6 | 2025 | 24 | 1.650 |
Why?
| | Brain Ischemia | 4 | 2020 | 321 | 1.240 |
Why?
| | Endocarditis | 2 | 2019 | 37 | 1.210 |
Why?
| | Anticoagulants | 7 | 2025 | 636 | 1.060 |
Why?
| | Neurology | 2 | 2024 | 102 | 0.990 |
Why?
| | Fibrinolytic Agents | 3 | 2024 | 262 | 0.810 |
Why?
| | Cerebral Arteries | 1 | 2022 | 60 | 0.760 |
Why?
| | Thrombophilia | 1 | 2021 | 81 | 0.700 |
Why?
| | Neurologists | 1 | 2020 | 20 | 0.690 |
Why?
| | Atrial Fibrillation | 2 | 2024 | 376 | 0.660 |
Why?
| | Diagnostic Tests, Routine | 1 | 2021 | 102 | 0.660 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2020 | 68 | 0.640 |
Why?
| | Intracranial Hemorrhages | 2 | 2024 | 78 | 0.630 |
Why?
| | Thrombectomy | 2 | 2022 | 58 | 0.630 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 3 | 2023 | 11 | 0.620 |
Why?
| | Cerebral Angiography | 1 | 2018 | 108 | 0.590 |
Why?
| | Computed Tomography Angiography | 1 | 2018 | 114 | 0.550 |
Why?
| | Ischemic Attack, Transient | 3 | 2023 | 60 | 0.540 |
Why?
| | Cerebrovascular Circulation | 1 | 2018 | 227 | 0.520 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 234 | 0.520 |
Why?
| | Thrombolytic Therapy | 3 | 2024 | 137 | 0.490 |
Why?
| | Pregnancy Complications | 1 | 2020 | 493 | 0.480 |
Why?
| | Internship and Residency | 1 | 2023 | 1047 | 0.440 |
Why?
| | Hospitalization | 3 | 2020 | 2052 | 0.420 |
Why?
| | Platelet Aggregation Inhibitors | 4 | 2025 | 442 | 0.390 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1267 | 0.370 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 483 | 0.370 |
Why?
| | Brain | 2 | 2023 | 2669 | 0.350 |
Why?
| | Venous Thrombosis | 2 | 2022 | 175 | 0.340 |
Why?
| | Endovascular Procedures | 2 | 2024 | 301 | 0.320 |
Why?
| | Humans | 32 | 2025 | 129266 | 0.300 |
Why?
| | Intracranial Embolism | 2 | 2019 | 31 | 0.300 |
Why?
| | Smoking Cessation | 2 | 2023 | 405 | 0.280 |
Why?
| | Arteries | 3 | 2024 | 265 | 0.270 |
Why?
| | Young Adult | 7 | 2024 | 12391 | 0.270 |
Why?
| | Retrospective Studies | 16 | 2025 | 14461 | 0.270 |
Why?
| | Diagnostic Errors | 2 | 2024 | 162 | 0.260 |
Why?
| | Aged, 80 and over | 8 | 2023 | 7055 | 0.240 |
Why?
| | Risk Factors | 11 | 2025 | 9745 | 0.240 |
Why?
| | Treatment Outcome | 8 | 2024 | 10202 | 0.230 |
Why?
| | Smoking | 3 | 2023 | 1499 | 0.230 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2024 | 78 | 0.220 |
Why?
| | Vasospasm, Intracranial | 1 | 2023 | 17 | 0.220 |
Why?
| | Aged | 13 | 2025 | 22032 | 0.210 |
Why?
| | Female | 20 | 2025 | 68551 | 0.210 |
Why?
| | Noma | 1 | 2023 | 2 | 0.210 |
Why?
| | Adult | 13 | 2025 | 35495 | 0.210 |
Why?
| | Cerebrovascular Disorders | 1 | 2023 | 90 | 0.200 |
Why?
| | Renal Colic | 1 | 2022 | 3 | 0.200 |
Why?
| | Middle Aged | 14 | 2025 | 31090 | 0.200 |
Why?
| | Status Epilepticus | 1 | 2023 | 42 | 0.200 |
Why?
| | Cerebral Veins | 1 | 2022 | 15 | 0.200 |
Why?
| | Dabigatran | 1 | 2022 | 21 | 0.190 |
Why?
| | Intracranial Thrombosis | 1 | 2022 | 16 | 0.190 |
Why?
| | Administration, Oral | 2 | 2022 | 785 | 0.190 |
Why?
| | Warfarin | 1 | 2022 | 147 | 0.180 |
Why?
| | United States | 7 | 2024 | 13826 | 0.180 |
Why?
| | Education, Medical | 1 | 2024 | 244 | 0.180 |
Why?
| | Tissue Plasminogen Activator | 2 | 2024 | 222 | 0.170 |
Why?
| | Fellowships and Scholarships | 1 | 2023 | 273 | 0.170 |
Why?
| | Drug Substitution | 1 | 2020 | 51 | 0.170 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2020 | 11 | 0.170 |
Why?
| | Pregnancy | 3 | 2024 | 6390 | 0.170 |
Why?
| | Mobile Health Units | 1 | 2019 | 19 | 0.160 |
Why?
| | Drug Utilization | 1 | 2020 | 171 | 0.160 |
Why?
| | Ambulances | 1 | 2019 | 51 | 0.160 |
Why?
| | Pregnant Women | 1 | 2020 | 114 | 0.160 |
Why?
| | Thrombosis | 1 | 2022 | 343 | 0.150 |
Why?
| | Registries | 4 | 2019 | 1895 | 0.150 |
Why?
| | Health Care Surveys | 1 | 2020 | 557 | 0.150 |
Why?
| | Geography | 1 | 2019 | 186 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 569 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2019 | 179 | 0.150 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 1949 | 0.140 |
Why?
| | Troponin | 1 | 2017 | 50 | 0.140 |
Why?
| | Male | 14 | 2025 | 63512 | 0.140 |
Why?
| | Health Surveys | 1 | 2019 | 493 | 0.130 |
Why?
| | Incidence | 2 | 2024 | 2636 | 0.130 |
Why?
| | Survivors | 1 | 2020 | 457 | 0.130 |
Why?
| | Sex Factors | 2 | 2020 | 1965 | 0.130 |
Why?
| | Adolescent | 3 | 2020 | 20313 | 0.130 |
Why?
| | Stroke Volume | 1 | 2019 | 592 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 385 | 0.120 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 527 | 0.120 |
Why?
| | Medication Adherence | 1 | 2020 | 556 | 0.120 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 1896 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1021 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2020 | 3377 | 0.100 |
Why?
| | Age Factors | 1 | 2019 | 3140 | 0.090 |
Why?
| | Depression | 1 | 2020 | 1306 | 0.090 |
Why?
| | Administration, Intravenous | 2 | 2024 | 141 | 0.090 |
Why?
| | Inpatients | 2 | 2024 | 462 | 0.080 |
Why?
| | Risk Assessment | 3 | 2024 | 3232 | 0.080 |
Why?
| | New York City | 2 | 2019 | 80 | 0.080 |
Why?
| | Databases, Factual | 2 | 2024 | 1266 | 0.080 |
Why?
| | Seizures | 2 | 2023 | 401 | 0.070 |
Why?
| | Odds Ratio | 2 | 2020 | 1019 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1365 | 0.060 |
Why?
| | Medicare | 2 | 2020 | 706 | 0.060 |
Why?
| | Delayed Diagnosis | 1 | 2024 | 78 | 0.060 |
Why?
| | Time Factors | 2 | 2024 | 6543 | 0.060 |
Why?
| | Logistic Models | 2 | 2020 | 1985 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2023 | 43 | 0.050 |
Why?
| | American Heart Association | 1 | 2024 | 296 | 0.050 |
Why?
| | Vasoconstriction | 1 | 2023 | 199 | 0.050 |
Why?
| | Recurrence | 1 | 2025 | 1005 | 0.050 |
Why?
| | Child | 1 | 2020 | 20785 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2024 | 846 | 0.040 |
Why?
| | Bupropion | 1 | 2020 | 40 | 0.040 |
Why?
| | Varenicline | 1 | 2020 | 25 | 0.040 |
Why?
| | Cohort Studies | 2 | 2023 | 5409 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7123 | 0.040 |
Why?
| | Comorbidity | 1 | 2024 | 1544 | 0.040 |
Why?
| | Urban Health | 1 | 2019 | 79 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2020 | 110 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 678 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5050 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2020 | 260 | 0.040 |
Why?
| | Patient Discharge | 1 | 2024 | 835 | 0.040 |
Why?
| | Communication | 1 | 2024 | 836 | 0.040 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 105 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 514 | 0.030 |
Why?
| | Up-Regulation | 1 | 2017 | 839 | 0.030 |
Why?
| | Patient Safety | 1 | 2017 | 285 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1497 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4887 | 0.030 |
Why?
| | Biomarkers | 1 | 2017 | 3968 | 0.020 |
Why?
|
|
Salehi Omran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|